Search
for
Sort by
Research 151–180 of 891
- New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature
- Gender‐affirming hormone therapy for transgender and gender‐diverse adults in Australia
- The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial
- Clinical markers of hyperandrogenism and response to conventional antibiotic therapy in women with acne vulgaris
- Recurrent episodes of hair loss in a 37 year old woman
- Spironolactone is an Effective and Well Tolerated Systemic Antiandrogen Therapy for Hirsute Women*
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients
- Compliance With Contraceptives and Other Treatments
- Anti-androgenic and Hair Growth Promoting Activities of Lygodii Spora (Spore of Lygodium japonicum) I. Active Constituents Inhibiting Testosterone 5.ALPHA.-Reductase.
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study
- Contraception and the dermatologist
- Androgenic effects of oral contraceptives: Implications for patient compliance
- Cross-sex hormone therapy for gender dysphoria
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Acquired Uncombable Hair
- Synergistic Potential of Ecklonia cava and Oral Contraceptives inManaging Polycystic Ovary Syndrome: Clinical and BiochemicalEvaluation
- Pharmacokinetic and Therapeutic Dose Comparison of Diane-35 and IVF-C Inj 5000 IU in Common Quail
- Management of women with hirsutism in Kosovo
- Steroid Hormones of Reproduction and Sexual Development
- CONTRACEPTION AND THE SKIN
- Teriflunomide in multiple sclerosis: an update
- Spironolactone treatment of porphyria cutanea tarda-associated hirsutism
- Hair Loss in Women
- Acne and Systemic Disease
- Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis